Clinical Trial Update: Hydralazine and Valproate Added to Chemotherapy for Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating adding hydralazine and valproate to chemotherapy for locally advanced breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Hydralazine (hydralazine)
• Valproate (valproate)

Snippet

Sponsor: National Institute of Cancerología | Conditions: Locally Advanced Breast Cancer | Phase 2 | Status: TERMINATED